
The FDA's Risky Drug Approvals and Transparency Concerns
ProPublica's year-long investigation reveals that the FDA has allowed over 150 drugs from banned factories, mainly in India, into the U.S. market without routine testing or public warning, raising concerns about drug safety and oversight.

